🇺🇸 FDA
Patent

US 12319748

Antibody binding to human HER2 and preparation method and use thereof

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 12319748 (Antibody binding to human HER2 and preparation method and use thereof) held by SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
Grant date
Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K2039/507, A61P, A61P35/00